Novo Nordisk’s Sickle Cell Drug Delivers as Buyback Program Advances
Novo Nordisk’s oral sickle cell drug etavopivat met Phase 3 goals, cutting painful crises by 27%. The success…
Novo Nordisk Ups the Ante with Wegovy HD Rollout
In a significant development for the weight-loss drug market, Novo Nordisk has introduced a higher-dose version of…
Novo Nordisk Faces Pivotal Moment in Oral Weight-Loss Drug Race
Novo Nordisk releases Wegovy pill data ahead of Lilly’s launch as analysts cut targets citing competition and pipeline…
Novo Nordisk’s Pipeline Successor Outperforms Flagship Weight-Loss Drug
New clinical data shows UBT251 leads to 9.8% weight loss vs. semaglutide’s 4.8%, as Novo Nordisk expands its…
Novo Nordisk Slashes U.S. Drug Prices in Competitive Countermove
Novo, Nordisk
26.03.2026 – 03:56:40 | boerse-global.de
Novo Nordisk cuts U.S. prices for Ozempic…
Novo Nordisk Expands Obesity Portfolio with Oral Drug Trial
Novo, Nordisk
25.03.2026 – 03:57:51 | boerse-global.de
Novo Nordisk expands its weight-loss strategy with…
Novo Nordisk Navigates Patent Expiry and Enhanced Drug Approval
Novo Nordisk gains FDA approval for potent Wegovy HD while facing generic competition in India after semaglutide patent…
Regulatory Scrutiny Intensifies for Novo Nordisk Over Drug Safety Reporting
Regulatory, Scrutiny
15.03.2026 – 03:44:25 | boerse-global.de
FDA mandates corrective action after inspection finds…
Novo Nordisk Faces Mounting Competition in Key Diabetes Drug Market
Aspen Pharmacare targets 2026 generic Ozempic launch in Canada after semaglutide patent expiry, pressuring Novo Nordisk amid a…
Corrupt Brussels Airport staff involved in huge spike in drug trafficking
Brussels Airport is under intense scrutiny as Belgian authorities warn it has become a key entry point for…
Novo Nordisk taps start-up for new oral weight-loss drugs
Fresh off the launch of its semaglutide pill, Novo Nordisk has entered a partnership with a start-up…
Novo Nordisk Shifts Strategy as US Weight-Loss Drug Price War Intensifies
The battle for dominance in the lucrative US market for weight-loss medications is entering a new phase. In…